A patient with chronic hypertension has been prescribed Hydrochlorothiazide and presents with fatigue, palpitations, and an elevated LDL cholesterol level. Based on the new diagnostic findings, which nursing intervention is most appropriate to address the potential electrolyte imbalance and its effects?

C) Educate the patient on increasing dietary potassium intake to prevent symptoms of hypokalemia.

A) Encourage the patient to increase dietary sodium intake to balance electrolyte levels.

B) Monitor the patient's blood glucose levels closely due to the risk of insulin resistance.

C) Educate the patient on increasing dietary potassium intake to prevent symptoms of hypokalemia.

D) Advise the patient to limit physical activity until the fatigue subsides.

A patient with hypertension and borderline hyperlipidemia presents with fatigue, shortness of breath, and palpitations. Recent diagnostic results show left ventricular hypertrophy and a slightly reduced potassium level due to diuretic use. Which nursing intervention is most appropriate to address the patient's current symptoms and reduce future cardiovascular risk?

B) Recommend the patient increase dietary potassium intake through foods like bananas and spinach.

A) Educate the patient on the importance of adhering to a low-sodium diet.

B) Recommend the patient increase dietary potassium intake through foods like bananas and spinach.

C) Instruct the patient on the benefits of engaging in daily aerobic exercise.

D) Advise the patient to take their diuretic medication in the evening to minimize daytime symptoms.

A patient with hypertension and left ventricular hypertrophy has been started on a calcium channel blocker. During a follow-up visit, the patient reports dizziness upon standing and chest discomfort during physical activity. Which of the following nursing interventions should be prioritized to address the patient's symptoms?

A) Educate the patient on slowly changing positions to prevent dizziness.

B) Increase the dosage of the calcium channel blocker to improve chest discomfort.

C) Encourage the patient to engage in more physical activity to improve cardiovascular health.

D) Advise the patient to discontinue the calcium channel blocker immediately.

A patient with a history of hypertension has been experiencing dizziness upon standing and chest discomfort during physical activity after starting a calcium channel blocker. Which nursing intervention is most appropriate to address the patient's current symptoms?

C) Educate the patient on the importance of gradual position changes to prevent dizziness.

A) Encourage the patient to increase fluid intake to help manage dizziness.

B) Advise the patient to take the medication at bedtime to reduce dizziness.

C) Educate the patient on the importance of gradual position changes to prevent dizziness.

D) Suggest the patient avoid physical activity to prevent chest discomfort.

A patient with coronary artery disease undergoes a treatment plan adjustment that includes the addition of a statin, low-dose aspirin, and a calcium channel blocker. Which assessment finding would indicate that the treatment plan is effective in managing the patient's condition?

B) The patient's LDL cholesterol levels have decreased significantly.

A) The patient reports increased frequency of anginal episodes.

B) The patient's LDL cholesterol levels have decreased significantly.

C) The patient experiences orthostatic hypotension upon standing.

D) The patient's blood pressure remains consistently elevated.

A patient with coronary artery disease and angina pectoris has been prescribed a new medication regimen, including a statin and low-dose aspirin. During a follow-up visit, the patient reports muscle pain and weakness. Which action should the nurse take first?

C) Assess the patient's serum creatine kinase (CK) level and notify the healthcare provider.

A) Encourage the patient to increase fluid intake to prevent dehydration.

B) Advise the patient to stop taking the aspirin until further evaluation.

C) Assess the patient's serum creatine kinase (CK) level and notify the healthcare provider.

D) Recommend the patient reduce physical activity until symptoms subside.

A patient presents with lightheadedness upon standing, a blood pressure of 132/78 mmHg, a heart rate of 68 bpm, and occasional PVCs with a potassium level of 3.4 mmol/L. Which nursing intervention is the most appropriate to address these findings?

A) Educate the patient on consuming foods high in potassium and consider a low-dose potassium supplement.

B) Increase the patient's calcium channel blocker dosage to manage PVCs.

C) Advise the patient to reduce fluid intake to manage hypertension.

D) Encourage the patient to engage in more vigorous physical activity to improve cardiac function.

A patient with a history of hypertension and recent adjustments in their treatment plan reports occasional lightheadedness upon standing. The healthcare team identifies borderline low potassium levels and mild left ventricular hypertrophy. Which nursing intervention should be prioritized to address the patient's current symptoms and findings?

B) Instruct the patient to rise slowly from sitting or lying positions to minimize the risk of orthostatic hypotension.

A) Educate the patient on increasing dietary sodium intake to counteract orthostatic hypotension.

B) Instruct the patient to rise slowly from sitting or lying positions to minimize the risk of orthostatic hypotension.

C) Recommend the patient take their calcium channel blocker at night to reduce daytime lightheadedness.

D) Advise the patient to avoid physical activity to prevent exacerbation of premature ventricular contractions (PVCs).

A patient with hypertension on antihypertensive therapy presents with orthostatic lightheadedness and signs of mild dehydration. Given this clinical scenario, which nursing intervention is most appropriate to address the patient's symptoms while maintaining blood pressure control?

B) Encourage the patient to consume more fluids and monitor their blood pressure regularly.

A) Increase the patient's diuretic dosage to further reduce blood pressure.

B) Encourage the patient to consume more fluids and monitor their blood pressure regularly.

C) Advise the patient to decrease salt intake to prevent fluid retention.

D) Recommend the patient perform leg exercises before standing to improve circulation.

A patient with a recent history of chest discomfort and newly developed orthostatic lightheadedness has been adhering to lifestyle modifications and is on antihypertensive therapy. The patient's vital signs show blood pressure at 130/76 mmHg and heart rate at 70 bpm, with signs of mild dehydration. What is the most appropriate nursing intervention to address the patient's current symptoms?

B) Educate the patient about the importance of slow position changes to minimize orthostatic symptoms

A) Increase the dosage of the antihypertensive medication to control blood pressure more effectively

B) Educate the patient about the importance of slow position changes to minimize orthostatic symptoms

C) Encourage the patient to limit fluid intake to avoid exacerbating potential fluid overload

D) Discontinue the current antihypertensive therapy and initiate a different class of medication

Hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased systemic vascular resistance - Hypertension often results from elevated resistance in the arterioles, caused by factors such as chronic endothelial dysfunction, leading to vasoconstriction. This requires the heart to pump harder, increasing blood pressure.

• Secondary mechanism: Renin-angiotensin-aldosterone system (RAAS) activation - Overactivation of RAAS can cause sodium retention and vasoconstriction. Angiotensin II increases blood pressure by narrowing blood vessels, while aldosterone promotes water and sodium retention, increasing blood volume.

• Key complication: Left ventricular hypertrophy - Chronic high blood pressure forces the heart to work harder, causing the left ventricle to thicken. This adaptation can lead to heart failure over time due to decreased cardiac efficiency and increased oxygen demand.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Diagnosed with hypertension 5 years ago, borderline hyperlipidemia

• Current medications: Lisinopril 20 mg daily, Hydrochlorothiazide 25 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headaches and occasional dizziness

• Key symptoms: Fatigue, shortness of breath on exertion, occasional palpitations

• Vital signs: Blood pressure 160/100 mmHg, heart rate 92 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

New Diagnostic Results:

Following the initial assessment, the attending physician ordered a series of tests to further evaluate the patient's condition. The laboratory results revealed elevated low-density lipoprotein (LDL) cholesterol levels at 160 mg/dL, which is above the recommended level for patients with hypertension and borderline hyperlipidemia. Fasting blood glucose was slightly elevated at 105 mg/dL, indicating a potential risk for insulin resistance, a common comorbidity in patients with chronic hypertension. Echocardiography confirmed the presence of left ventricular hypertrophy, showing an increased left ventricular wall thickness of 15 mm. This structural change correlates with the patient's ongoing symptoms of fatigue and shortness of breath, suggesting that the heart is struggling to maintain efficient circulation.

The physician also ordered a comprehensive metabolic panel, which showed normal kidney function but a slightly reduced potassium level at 3.4 mEq/L, likely due to the diuretic effect of Hydrochlorothiazide. This electrolyte imbalance could contribute to the patient's palpitations and fatigue. These findings emphasize the need to address the broader cardiovascular risk profile, focusing on both blood pressure control and lipid management to prevent further complications.

The patient's current medication regimen may require adjustment to better manage his hypertension and associated risks. Considering the suboptimal blood pressure control and new evidence of left ventricular hypertrophy, the healthcare team is considering intensifying the antihypertensive therapy, potentially adding a calcium channel blocker or a beta-blocker to the treatment plan. Additionally, lifestyle modifications, including dietary changes and increased physical activity, will be discussed to address both hypertension and hyperlipidemia. These steps aim to reduce the patient's long-term cardiovascular risk and improve his overall quality of life.

Section 2

Change in Patient Status:

Two weeks after initiating the updated treatment plan, which included the addition of a calcium channel blocker, the patient returned for a follow-up visit. During the assessment, the nurse noted that the patient's blood pressure had improved, measuring 135/85 mmHg, demonstrating partial success in hypertension management. However, the patient reported experiencing increased episodes of dizziness, particularly upon standing, raising concerns about potential orthostatic hypotension, a known side effect of the new medication. This symptom suggests that while the medication has been effective in lowering blood pressure, it may also be contributing to decreased vascular resistance, necessitating careful monitoring and possible dosage adjustment.

Additionally, the patient disclosed experiencing more frequent episodes of chest discomfort, described as a tightness during physical activity, which subsided with rest. Given the patient's history of left ventricular hypertrophy and elevated LDL cholesterol, this raises the suspicion of angina pectoris, indicating that the heart might not be receiving adequate oxygen supply during exertion. This development could imply that while blood pressure control is improving, coronary artery disease risk may be escalating, warranting further cardiac evaluation and possibly an adjustment in the treatment approach to address both ischemic and hypertensive concerns.

In response to these new symptoms, the healthcare team is considering further diagnostic testing, including a stress test and possibly a coronary angiography, to investigate the extent of any coronary artery disease. In conjunction with these investigations, the team will assess the need for additional pharmaceutical interventions, such as a statin or low-dose aspirin, to manage the patient's cardiovascular risk more comprehensively. The evolving clinical picture underscores the complexity of managing hypertension with comorbid conditions and highlights the importance of a holistic approach to treatment, guided by ongoing assessment and clinical reasoning.

Section 3

Following the decision to conduct further diagnostic testing, the patient underwent a stress test, which revealed mild to moderate ischemic changes during exertion, indicating a compromised blood flow to the heart muscle. This finding confirmed the suspicion of angina pectoris, likely due to underlying coronary artery disease. In light of these results, the healthcare team proceeded with a coronary angiography, which identified a 70% stenosis in the mid-left anterior descending artery and a 50% stenosis in the right coronary artery. These findings suggest significant atherosclerotic disease, necessitating a re-evaluation of the current treatment strategy to prevent potential myocardial infarction.

In response to these diagnostic results, the healthcare team initiated changes to the patient's medication regimen. The patient was started on a statin to aggressively manage elevated LDL cholesterol levels and reduce further plaque buildup in the coronary arteries. Additionally, a low-dose aspirin was prescribed to decrease the risk of thrombus formation. The calcium channel blocker dosage was adjusted to minimize the risk of orthostatic hypotension while maintaining adequate blood pressure control. The patient was also advised on lifestyle modifications, including dietary changes to reduce cholesterol and a tailored exercise program, with precautions to avoid activities that could precipitate anginal episodes.

The patient's response to these interventions will be closely monitored, with follow-up visits scheduled to assess the effectiveness of the revised treatment plan. The healthcare team will pay particular attention to the patient's cardiovascular symptoms and blood pressure levels, ensuring that the therapeutic adjustments effectively balance the management of hypertension and coronary artery disease. This strategic approach aims to optimize the patient's cardiovascular health, prevent further complications, and enhance overall quality of life. The next steps will likely involve regular monitoring of lipid profiles and blood pressure, as well as patient education to reinforce adherence to the treatment plan and lifestyle recommendations.

Section 4

Two weeks following the initiation of the revised treatment plan, the patient returned for a follow-up appointment. During the initial assessment, the patient reported a significant reduction in the frequency and intensity of anginal episodes, experiencing only occasional mild chest discomfort during exertion. Vital signs revealed a blood pressure of 132/78 mmHg and a heart rate of 68 beats per minute, indicating improved control of hypertension. The patient’s lipid profile showed a notable decrease in LDL cholesterol levels from 160 mg/dL to 120 mg/dL, reflecting the efficacy of the statin therapy. Despite these improvements, the patient mentioned occasional lightheadedness upon standing, suggesting the possibility of orthostatic hypotension, likely related to the adjusted dosage of the calcium channel blocker.

In light of these findings, the healthcare team decided to conduct additional diagnostic tests, including an echocardiogram to evaluate cardiac function and a 24-hour Holter monitor to assess for any arrhythmias that might contribute to the patient's lightheadedness. The echocardiogram revealed mild left ventricular hypertrophy, consistent with the history of hypertension, but no significant changes in ejection fraction. The Holter monitor demonstrated occasional premature ventricular contractions (PVCs), which were deemed benign at this stage. However, the presence of PVCs prompted a re-evaluation of electrolyte levels, which showed borderline low potassium at 3.4 mmol/L, necessitating dietary adjustments and possible supplementation.

Given these developments, the healthcare team reinforced the importance of dietary potassium intake through foods such as bananas and spinach and considered a low-dose potassium supplement to prevent further complications. The patient was educated about recognizing symptoms of significant orthostatic hypotension and encouraged to rise slowly from sitting or lying positions. Moving forward, the focus will be on optimizing medication regimens to further stabilize blood pressure and lipid levels while addressing the new findings, such as electrolyte imbalances and PVCs, to prevent progression to more severe cardiovascular complications.

Section 5

Two weeks after the latest adjustments to the treatment plan, the patient returned for another follow-up appointment. During the initial assessment, the patient reported a further reduction in episodes of chest discomfort, now describing them as rare and very mild. However, the patient expressed concerns about increased episodes of lightheadedness, particularly when transitioning from sitting to standing, despite adhering to the recommended lifestyle modifications. Vital signs indicated a blood pressure of 130/76 mmHg and a heart rate of 70 beats per minute. Interestingly, the patient showed signs of mild dehydration, potentially contributing to the orthostatic symptoms, as evidenced by slightly elevated blood urea nitrogen (BUN) levels at 23 mg/dL and hematocrit at 47%, both on the higher end of normal.

In response to these new findings, the healthcare team considered further refinement of the patient's medication regimen, particularly focusing on the potential diuretic effect of the current antihypertensive therapy, which might be exacerbating the mild dehydration and electrolyte imbalance. Additionally, the team decided to monitor the patient's fluid intake closely and educate the patient on maintaining adequate hydration without compromising blood pressure control. The patient's current potassium level was re-evaluated and found to be slightly improved at 3.6 mmol/L, suggesting that dietary adjustments were beginning to have a positive effect. However, the team emphasized the need for ongoing monitoring to prevent any adverse outcomes related to electrolyte disturbances.

As the healthcare team continued to manage the patient's condition, they remained vigilant for any signs of progression towards more severe complications, such as worsening arrhythmias or cardiac function. The decision was made to schedule a follow-up appointment in four weeks with a focus on reassessing cardiovascular risk factors and ensuring that both blood pressure and electrolyte levels remain stable. This approach aimed to preemptively address any emerging concerns and optimize the patient's overall cardiovascular health, while also providing an opportunity to evaluate the effectiveness of current interventions and make necessary adjustments.